Protein Biomarkers and Neuroproteomics Characterization of Microvesicles/Exosomes from Human Cerebrospinal Fluid Following Traumatic Brain Injury

dc.contributor.authorManek, Rachna
dc.contributor.authorMoghieb, Ahmed M.
dc.contributor.authorYang, Zhihui
dc.contributor.authorKumar, Dhwani
dc.contributor.authorKobeissy, Firas H.
dc.contributor.authorSarkis, George Anis
dc.contributor.authorRaghavan, Vijaya
dc.contributor.authorWang, Kevin Ka Wang
dc.contributor.departmentBiochemistry and Molecular Genetics
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:37:58Z
dc.date.available2025-01-24T11:37:58Z
dc.date.issued2018
dc.description.abstractRecently, there have been emerging interests in the area of microvesicles and exosome (MV/E) released from brain cells in relation to neurodegenerative diseases. However, only limited studies focused on MV/E released post-traumatic brain injury (TBI) as they highlight on the mechanistic roles of released proteins. This study sought to examine if CSF samples from severe TBI patients contain MV/E with unique protein contents. First, nanoparticle tracking analysis determined MV/E from TBI have a mode of 74–98 nm in diameter, while control CSF MV/E have a mode of 99–104 nm. Also, there are more MV/E were isolated from TBI CSF (27.8–33.6 × 108/mL) than from control CSF (13.1–18.5 × 108/mL). Transmission electron microscopy (TEM) visualization also confirmed characteristic MV/E morphology. Using targeted immunoblotting approach, we observed the presence of several known TBI biomarkers such as αII-spectrin breakdown products (BDPs), GFAP, and its BDPs and UCH-L1 in higher concentrations in MV/E from TBI CSF than their counterparts from control CSF. Furthermore, we found presynaptic terminal protein synaptophysin and known exosome marker Alix enriched in MV/E from human TBI CSF. In parallel, we conducted nRPLC-tandem mass spectrometry-based proteomic analysis of two control and two TBI CSF samples. Ninety-one proteins were identified with high confidence in MV/E from control CSF, whereas 466 proteins were identified in the counterpart from TBI CSF. MV/E isolated from human CSF contain cytoskeletal proteins, neurite-outgrowth related proteins, and synaptic proteins, extracellular matrix proteins, and complement protein C1q subcomponent subunit B. Taken together, following severe TBI, the injured human brain released increased number of extracellular microvesicles/exosomes (MV/E) into CSF. These TBI MV/E contain several known TBI biomarkers and previously undescribed brain protein markers. It is also possible that such TBI-specific MV/E might contain cell to cell communication factors related to both cell death signaling a well as neurodegeneration pathways. © 2017, Springer Science+Business Media, LLC, part of Springer Nature.
dc.identifier.doihttps://doi.org/10.1007/s12035-017-0821-y
dc.identifier.eid2-s2.0-85035341217
dc.identifier.pmid29188495
dc.identifier.urihttp://hdl.handle.net/10938/28940
dc.language.isoen
dc.publisherHumana Press Inc.
dc.relation.ispartofMolecular Neurobiology
dc.sourceScopus
dc.subjectBiomarkers
dc.subjectExosome
dc.subjectGlial injury
dc.subjectMicrovesicles
dc.subjectNeuronal injury
dc.subjectSystems biology
dc.subjectTraumatic brain injury
dc.subjectBrain injuries, traumatic
dc.subjectCase-control studies
dc.subjectDynamic light scattering
dc.subjectExosomes
dc.subjectHumans
dc.subjectNeuroglia
dc.subjectNeurons
dc.subjectProteolysis
dc.subjectProteome
dc.subjectProteomics
dc.subjectSignal transduction
dc.subjectAlpha ii spectrin
dc.subjectBiological marker
dc.subjectComplement component c1q
dc.subjectCytoskeleton protein
dc.subjectGlial fibrillary acidic protein
dc.subjectNanoparticle
dc.subjectNeurite promoting factor
dc.subjectScleroprotein
dc.subjectSpectrin
dc.subjectSynapse receptor
dc.subjectUbiquitin carboxy terminal hydrolase 1
dc.subjectUbiquitin thiolesterase
dc.subjectUnclassified drug
dc.subjectAdult
dc.subjectArticle
dc.subjectCell communication
dc.subjectCell death
dc.subjectCell isolation
dc.subjectCell structure
dc.subjectCerebrospinal fluid
dc.subjectClinical article
dc.subjectConcentration (parameters)
dc.subjectControlled study
dc.subjectDisease severity
dc.subjectHuman
dc.subjectHuman cell
dc.subjectImmunoblotting
dc.subjectMembrane microparticle
dc.subjectNerve degeneration
dc.subjectProtein analysis
dc.subjectReversed phase liquid chromatography
dc.subjectTransmission electron microscopy
dc.subjectCase control study
dc.subjectGlia
dc.subjectMetabolism
dc.subjectNerve cell
dc.subjectPhoton correlation spectroscopy
dc.subjectProtein degradation
dc.subjectUltrastructure
dc.titleProtein Biomarkers and Neuroproteomics Characterization of Microvesicles/Exosomes from Human Cerebrospinal Fluid Following Traumatic Brain Injury
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2018-8181.pdf
Size:
848.75 KB
Format:
Adobe Portable Document Format